Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
2019 · Journal of Hepatology · 346 citations
https://doi.org/10.1016/j.jhep.2019.11.003
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
2.4K
Citations
21
h-index
22
i10-index
Anna Suk‐Fong Lok is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Hepatitis B Virus Studies & Hepatitis C virus research & Liver Disease Diagnosis and Treatment. The author has an h-index of 21, co-authored 35 publications.
Click to start Chat